Current status of specific pediatric chronic diseases in Japan: National measures, disease types, treatment availability, copayment assistance, and research
Current status of specific pediatric chronic diseases in Japan: National measures, disease types, treatment availability, copayment assistance, and research
复制标题
DOI：
10.5582/irdr.2021.01145
复制
发表时间：
2021-11-01
影响因子：
1.3
通讯作者：
Sawakami, Tatsuo
中科院分区：
文献类型：
--
作者：
Sawakami, Tatsuo
在日本，截至2021年11月1日，特定儿科慢性病包括16组疾病、278个类别和845个子类别的788种疾病。国家特定儿科慢性病措施-也称为特定类别慢性儿科疾病医疗援助计划（MAPChD）-于1974年在日本制定，并于2005年写入法律。患有特定儿科慢性疾病的患者可以通过以下几种方式获得政府支持和福利：i）MAPChD要求在指定医院和指定医生进行诊断和治疗，以便患者获得最佳治疗; ii）医疗费用的自付率降至20%，最高限额取决于家庭收入;（三）继续推动从不同角度分析儿科慢性病的具体情况。除了这三个方面之外，正在实施各种措施，为患有特定儿科慢性疾病的患者在成长过程中提供持续支持。
In Japan, specific pediatric chronic diseases include 788 diseases in 16 groups of diseases, 278 categories, and 845 subcategories as of November 1, 2021. The national specific pediatric chronic diseases measures - also called the Medical Aid Program for Chronic Pediatric Diseases of Specified Categories (MAPChD) - was established in Japan in 1974 and enshrined in law in 2005. Patients with specific pediatric chronic diseases can receive government support and welfare in several ways: i) MAPChD requires diagnosis and medical treatment at designated hospitals and by designated physicians so that patients receive optimal treatment; ii) the copayment rate for medical expenses is reduced to 20% and a maximum is set depending on household income; and iii) the analysis of specific pediatric chronic diseases from different perspectives is continuously being promoted. In addition to these three aspects, various measures are being implemented to provide ongoing support for patients with specific pediatric chronic diseases as they grow up.